Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 1Keloid 1Cicatrix, Hypertrophic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fusidic Acid × Clear all
NCT00718315 2015-01-15

A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Hoffmann-La Roche

Phase 3 Completed
201 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01113125 2014-02-12

Scars After Central Venous Catheters

Aarhus University Hospital

Phase 3 Unknown
60 enrolled

Keloid, Neoplasms, Cicatrix, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡